ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Classification and immune invasion analysis of breast cancer based on m6A genes

Qin, Qiang; Fang, Da Lang; Zhou, Weijie; Meng, Yuhua*; Wei, Jie*南方医科大学; 1
Annals of Translational Medicine2021-9DOI: 10.21037/atm-21-3404
5被引4阅读
引用收藏
分享

摘要

Background: Breast cancer (BRCA) shows genetic, epigenetic, and phenotypic diversity. Methylation of N6-methyladenosine (m6A) affects the occurrence, development, and therapeutic efficacy of BRCA. However, the characteristics and prognostic value of m6A in BRCA remain unclear. We aimed to classify and construct a scoring system for the m6A regulatory gene in BRCA, and to explore its potential mechanisms. Methods: In this study, we selected 23 m6A regulatory genes and analyzed their genetic variation in BRCA, including copy number variation (CNV) data, expression differences, mutations, gene types, and correlations between genes. Survival curves were drawn by the Kaplan-Meier method, and a log-rank P<0.05 was considered statistically significant. The partitioning around medoids (PAM) algorithm was used for molecular subtype analysis of m6A, single-sample Gene Set Enrichment Analysis (ssGSEA) algorithm was used to quantify the relative infiltration levels of various immune cell subgroups, and a scoring system was built based on principal component analysis (PCA). Results: In BRCA, m6A regulatory gene mutation frequency is not high, while that of CNV mutation is high, which is related to gene expression and closely related to prognosis. In this study, we identified 3 different m6A subtypes, which are closely related to the level of immune cell infiltration. We further constructed an m6A score system, in which lower scores were correlated with low tumor mutation burden (TMB), later clinical staging, programmed cell death 1 ligand 1 (PD-L1) expression, and triple-negative breast cancer (TNBC). Conclusions: This study highlights the diversity and complexity of the role of m6A in BRCA. The classification of BRCA based on the m6A regulatory gene can help us understand the characteristics of BRCA and help develop individualized immunotherapy regimens.

学科与关键词

关键词
Breast cancerN6-methyladenosine (m6A)molecular subtypeimmune characteristics
相关
加载中…
  • Novel RNA N6-methyladenosine regulator related signature for predicting clinical and immunological characteristics in breast cancer
    Zhang, Jian; Liu, Guihong; Dai, Zili; Xie, Fuchuan; Zheng, Ronghui; Yuan, Benchao; Guo, Liyi*Gene, 2023, 853: 147095.
  • The emerging roles and mechanism of m6a in breast cancer progression
    Zhou, Mengying; Dong, Menglu; Yang, Xue; Gong, Jun; Liao, Xinghua*; Zhang, Qi*; Liu, Zeming*Frontiers in Genetics, 2022, 13: 983564.被引 3
  • Copy number variation analysis of m6A regulators identified METTL3 as a prognostic and immune-related biomarker in bladder cancer
    Wang, Xiaoshuai; Yu, Jingwei; Chen, Jinbao; Hou, Yingdong; Du, Zefeng; Huang, Haoyang; Tang, Siqi; Han, Yueyin; Ding, Changhai; Xue, Zhicheng*Cancer Medicine, 2021, 10(21): 7804-7815.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
Annals of Translational Medicine
发表日期
2021-09
卷期
第 9 卷, 第 18 期
DOI
10.21037/atm-21-3404
期刊收录
NSL
期刊等级
3区
成果收录
SCIE

作者

  • Q

    Qin, Qiang (第一作者)

    youjiang med univ nationalities

  • F

    Fang, Da Lang

    youjiang med univ nationalities

查看全部 5 位作者收起作者
  • Z

    Zhou, Weijie

  • M

    Meng, Yuhua (通讯)

    1 · southern med univ

  • W

    Wei, Jie (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417